Wockhardt shares rise 10% after Zaynich aids successful liver transplant trial 0 16.12.2024 07:57 Economictimes.indiatimes.com Wockhardt's shares surged 8.6% after its antibiotic Zaynich successfully treated a US cancer patient, enabling a liver transplant and chemotherapy. The drug is nearing Phase III trials for global approval. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
